Spicehealth by Spicejet has signed a Memorandum of Understanding (MoU) with CSIR – Centre for Cellular and Molecular Biology (CCMB), India, a constituent lab of the Council of Scientific and Industrial Research.

The MoU is for conducting dry swab direct RT-PCR tests in Spicehealth’s mobile testing laboratories in India.

The dry-swab direct RT-PCR method eliminates the requirement of new kits, heavy packaging and any additional training, making it a faster and easier process.

The Indian Council of Medical Research (ICMR) recently granted approval to CSIR-CCMB to commercially use the dry swab RNA-extraction free Covid testing method, which has the “potential to scale up testing by two to three-fold with no additional resources and significantly reduce the time and costs of such tests.”

The initiative follows the launch of an affordable and fast RT-PCR testing at ₹499 by Spicehealth. They currently have five functioning labs at government requested locations around Delhi NCR, conducting 10,000-15,000 tests per day.

Avani Singh, CEO, Spicehealth said, “I am proud to announce the launch of the first-of-its-kind dry swab RT-PCR testing facility at our Spicehealth laboratories.

“At SpiceHealth, our mission is to provide high-quality and low-cost healthcare on a large scale. The best way to achieve this goal is through innovation.

“The dry swab method, developed by CSIR-CCMB, will reduce testing time by 1.5 hours, significantly reduce cost and further revolutionise RT-PCR testing. Spicehealth is proud to be the first Indian laboratory to incorporate this method into its labs.”

Dr. Rakesh Mishra, director, CSIR-CCMB said:

“The dry swab testing method will be a game-changer in testing during the pandemic. The method is safer, faster, and cheaper than the current testing method without compromising the quality of test results.

“We are very happy that Spicehealth will use this technology in their mobile testing labs, and benefit a large number of people.”